K Number
K080364
Device Name
FINDRWIRZ GUIDE WIRE SYSTEM
Manufacturer
Date Cleared
2008-08-11

(182 days)

Product Code
Regulation Number
870.1330
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The FindrWIRZ System is intended for use in the cardiovascular system for introduction and positioning of over-the-wire catheters and therapeutic devices during interventional procedures. A FindrWIRZ may also be used to manipulate and or reposition another FindrWIRZ. The FindrWIRZ System is not intended for use in the coronary or cerebral vasculature.
Device Description
The FindrWIRZ System consists of the following components: A 0.035" x 90 cm FindrWIRZ A 0.025" x 260 cm FindrWIRZ Guide wire introducer Torque device Each FindrWIRZ is configured with a tapered core wire and a distal coil, the 0.035 FindrWIRZ has a proximal PTFE jacket and both wires have a hydrophilic coating. The distal tip of each wire has an encapsulated magnet of opposite polarization which is used for proximity sensing and connection of the two guide wires to facilitate manipulation and positioning of each other. The FindrWIRZ System is sterilized with 100% ethylene oxide.
More Information

Not Found

No
The description focuses on mechanical components and magnetic interaction, with no mention of AI/ML terms or data-driven functionalities.

No
The device is used for introduction and positioning of catheters and therapeutic devices, but is not itself a therapeutic device.

No

The device description clearly states its purpose is for "introduction and positioning of over-the-wire catheters and therapeutic devices," and for "manipulate and or reposition another FindrWIRZ." It facilitates interventional procedures by aiding in navigation and placement, rather than detecting or identifying a medical condition.

No

The device description explicitly lists physical components such as guide wires, a guide wire introducer, and a torque device, which are hardware.

Based on the provided information, the FindrWIRZ System is not an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use clearly states the device is for use in the cardiovascular system for introducing and positioning catheters and therapeutic devices during interventional procedures. This describes a device used in vivo (within a living organism).
  • Device Description: The description details a guide wire system with physical components designed for manipulation within the body.
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.

IVD devices are specifically designed to perform tests on samples taken from the body, not to be used within the body for therapeutic or procedural purposes.

N/A

Intended Use / Indications for Use

The FindrWIRZ System is intended for use in the cardiovascular system for introduction and positioning of over-the-wire catheters and therapeutic devices during interventional procedures. A FindrWIRZ may also be used to manipulate and or reposition another FindrWIRZ.

The FindrWIRZ System is not intended for use in the coronary or cerebral vasculature.

Product codes (comma separated list FDA assigned to the subject device)

DQX

Device Description

The FindrWIRZ System consists of the following components: A 0.035" x 90 cm FindrWIRZ A 0.025" x 260 cm FindrWIRZ Guide wire introducer Torque device

Each FindrWIRZ is configured with a tapered core wire and a distal coil, the 0.035 FindrWIRZ has a proximal PTFE jacket and both wires have a hydrophilic coating. The distal tip of each wire has an encapsulated magnet of opposite polarization which is used for proximity sensing and connection of the two guide wires to facilitate manipulation and positioning of each other. The FindrWIRZ System is sterilized with 100% ethylene oxide.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

cardiovascular system

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Functional testing was conducted to support the claim of substantial equivalence and to demonstrate the FindrWIRZ Guide Wire System is safe and effective for its intended use.

The materials used in the FindrWIRZ Guide Wire System are commonly used materials in other medical devices. Results of testing demonstrate the FindrWIRZ Guide Wire System is biocompatible.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

OnTrac, Lake Region (K914138), Cronus Wire, Stereotaxis (K042854), Radius Snare Device, Radius Medical Technologies (K071457)

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 870.1330 Catheter guide wire.

(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

0

page 1 of 2

SECTION 4 - 510(K) SUMMARY

This summary of 510(k)-safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

510(k) number: _KOB6364

Date Prepared: February 06, 2008 AUG 1 2 2008

Applicant Information: SentreHEART 2468 Embarcadero Way Palo Alto, CA 94303

Contact Person:

Linda Guthrie, Manager Regulatory Affairs Phone Number: (650) 354-1200 x105 Fax Number: (650) 354-1204

Device Information:

Trade Name:FindrWIRZ Guide Wire System
Classification:Class II per 21CFR 870.1330
Classification Name:Wire, Guide, Catheter
Product Code:DQX

Physical Description:

The FindrWIRZ System consists of the following components: A 0.035" x 90 cm FindrWIRZ A 0.025" x 260 cm FindrWIRZ Guide wire introducer Torque device

Each FindrWIRZ is configured with a tapered core wire and a distal coil, the 0.035 FindrWIRZ has a proximal PTFE jacket and both wires have a hydrophilic coating. The distal tip of each wire has an encapsulated magnet of opposite polarization which is used for proximity sensing and connection of the two guide wires to facilitate manipulation and positioning of each other. The FindrWIRZ System is sterilized with 100% ethylene oxide.

Intended Use:

The FindrWIRZ System is intended for use in the cardiovascular system for introduction and positioning of over-the-wire catheters and therapeutic devices during interventional procedures. A FindrWIRZ may also be used to manipulate and or reposition another FindrWIRZ.

1

SECTION 4 - 510(K) SUMMARY

page 2 of 2

The FindrWIRZ System is not intended for use in the coronary or cerebral vasculature. FindrWIRZ are not intended for use in crossing chronic total occlusions.

Contraindications: The FindrWIRZ system is contraindicated for use with rotational atherectorny devices, ferromagnetic interventional devices and Inferior Vena Cava (IVC) filters. The Findr WIRZ system is also contraindicated for use in MRI procedures.

Predicate Devices:

OnTrac, Lake Region (K914138) Cronus Wire, Stereotaxis (K042854) Radius Snare Device, Radius Medical Technologies (K071457)

Safety and Performance:

Performance

Functional testing was conducted to support the claim of substantial equivalence and to demonstrate the FindrWIRZ Guide Wire System is safe and effective for its intended use.

Biocompatibility

The materials used in the FindrWIRZ Guide Wire System are commonly used materials in other medical devices. Results of testing demonstrate the FindrWIRZ Guide Wire System is biocompatible.

Summary:

Based on the intended use, product testing, and information provided in this notification, the subject device has been shown to be safe and effective for its intended use and substantially equivalent to the predicate devices.

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of a human figure with three overlapping profiles, suggesting a sense of community and support. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the figure, emphasizing the organization's name and national scope.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 1 2 2006

Sentreheart Inc. c/o Ms. Linda Guthrie 2460 Embarcadero Way Palo Alto, CA 94303

Re: K080364 Trade/Device Name: FindrWirz Guidewire System Regulation Number: 21 CFR 870.1330 Regulatory Class: II Product Code: DQX Dated: July 16, 2008 Received: July 18, 2008

Dear Ms. Guthrie:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally

3

Page 2 - Ms. Linda Guthrie

marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

ff you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html,

Sincerely yours,

Donna R. Vachner

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

SECTION 3 - INDICATIONS FOR USE STATEMENT

510(k) Number (if known): __K080364

Device Name: FindrWIRZ Guide Wire System

Indications for Use: The FindrWIRZ System is intended for use in the cardiovascular system for introduction and positioning of over-the-wire catheters and therapeutic devices during interventional procedures. A FindrWIRZ may also be used to manipulate and or reposition another FindrWIRZ.

The FindrWIRZ System is not intended for use in the coronary or cerebral vasculature.

Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NO WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE)

Duna R. James

(Division Sign-Off) Division of Cardiovascular Devices

510(k) Number_Ko80364 SentreHEART CONFIDENTIAL

Page 6